Doctors involved with the historic procedure shared key details about their experience in the New England Journal of Medicine.

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions. 

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

A Hong Kong study examined incidence rate ratios for major adverse cardiovascular events in the 27 days following each vaccine dose. 

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care. 

A new study to examine the relationship between extreme-heat events and cardiovascular mortality found that the hottest days can indeed be deadly.

Continuous and high-adherent statin users had lower baseline arterial stiffness, which also grew more slowly over time. 

Hospitals have been required to post their prices of their 300 most common procedures since Jan. 1, 2021. However, a majority of providers are still not fully complying.